Welcome to LookChem.com Sign In|Join Free
  • or
C28H37N7O7 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1381760-75-3

Post Buying Request

1381760-75-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1381760-75-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1381760-75-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,1,7,6 and 0 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1381760-75:
(9*1)+(8*3)+(7*8)+(6*1)+(5*7)+(4*6)+(3*0)+(2*7)+(1*5)=173
173 % 10 = 3
So 1381760-75-3 is a valid CAS Registry Number.

1381760-75-3Downstream Products

1381760-75-3Relevant academic research and scientific papers

Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites

Van Haren, Matthijs,Van Ufford, Linda Quarles,Moret, Ed E.,Martin, Nathaniel I.

, p. 549 - 560 (2015/02/02)

The protein arginine N-methyltransferases (PRMTs) are a family of enzymes that function by specifically transferring a methyl group from the cofactor S-adenosyl-l-methionine (AdoMet) to the guanidine group of arginine residues in target proteins. The most notable is the PRMT-mediated methylation of arginine residues that are present in histone proteins which can lead to chromatin remodelling and influence gene transcription. A growing body of evidence now implicates dysregulated PRMT activity in a number of diseases including various forms of cancer. The development of PRMT inhibitors may therefore hold potential as a means of developing new therapeutics. We here report the synthesis and evaluation of a series of small molecule PRMT inhibitors designed to simultaneously occupy the binding sites of both the guanidino substrate and AdoMet cofactor. Potent inhibition and surprising selectivity were observed when testing these compounds against a panel of methyltransferases.

MODULATORS OF HISTONE METHYLTRANSFERASE, AND METHODS OF USE THEREOF

-

, (2012/06/30)

Disclosed are compounds, pharmaceutical compositions containing the compounds, and the uses of the compounds and compositions as modulators of histone methyltransferases, and for treating diseases influenced by modulation of histone methyltransferase activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1381760-75-3